Grey Wolf will be attending the SITC 2019 conference from 6th-10th November in Maryland, USA. The company’s Head of Biology, Lesley Young, will be presenting a poster on Grey Wolf’s lead programme targeting ERAP1, showing that optimised ERAP1 inhibitors modify the immunopeptidome and generate novel, immunogenic neoantigens.
Poster number: P817
Presentation date and time: Friday 8th November from 7am-8pm.